Skip to main content
. 2017 Oct 12;57(2):54–63. doi: 10.3960/jslrt.17029

Table 3. Initial treatment.

1st line therapy GCB (n=111) non-GCB (n=209) Total (n=320) P-value
n % n % n %
R-CHOP-like*1 96 86.5 195 93.3 291 90.9
Other regimens*2  6  5.4   5  2.4  11  3.4 -
Operation  1  0.9   1  0.5   2  0.6 -
Radiation  0 0   1  0.5   1  0.3 -
Not available*3  5  4.5   6  2.9  11  3.4 -
Unknown  3  2.7   1  0.5   4  1.3 -
Achieve CR1 86 77.5 110 52.6 196 61.3 1.28E-05

1* R-CHOP, R-THP-COP, Rw-CHOP, R-COP, R-CHP, R-CHO.

2* CHOP, R, DA-EPOCH-R, HDMA, Obinutuzumab-CHOP.

3* PSL.